BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 16681820)

  • 1. A case of bullous tinea pedis with dermatophytid reaction caused by Trichophyton violaceum.
    Romano C; Rubegni P; Ghilardi A; Fimiani M
    Mycoses; 2006 May; 49(3):249-50. PubMed ID: 16681820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of itraconazole to treat cutaneous fungal infections in children.
    Gupta AK; Nolting S; de Prost Y; Delescluse J; Degreef H; Theissen U; Wallace R; Marynissen G; De Doncker P
    Dermatology; 1999; 199(3):248-52. PubMed ID: 10592406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Widespread, chronic, and fluconazole-resistant Trichophyton rubrum infection in an immunocompetent patient.
    Balci DD; Cetin M
    Mycoses; 2008 Nov; 51(6):546-8. PubMed ID: 18422918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fundamental and clinical studies on the efficacy of bifonazole in patients with tinea pedis at 10 years after approval. Part 2. Clinical evaluation].
    Watanabe S; Takahashi H; Nakamura Y; Nakamura E; Nishiyama Y; Teduka M; Yamaguchi H; Uchida K; Tomizawa T; Shimozuma M; Osada A; Kawano S; Nakauchi Y; Wakukawa M; Goto A; Ueda Y; Matsukawa A; Minami H; Arikawa J; Soma Y; Chi HI; Tamaki K
    Jpn J Antibiot; 1996 Dec; 49(12):1095-108. PubMed ID: 9032596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Miconazol nitrate, a new broad spectrum antimycotic for local therapy in dermatomycoses. 3. Clinical results].
    Refai M
    Mykosen; 1973 Mar; 16(3):117-20. PubMed ID: 4576159
    [No Abstract]   [Full Text] [Related]  

  • 6. Miconazole treatment for severe dermatophytoses.
    Mandy SJ; Garrott TC
    JAMA; 1974 Oct; 230(1):72-5. PubMed ID: 4606810
    [No Abstract]   [Full Text] [Related]  

  • 7. Antifungal activity of the new agent latoconazole in two tinea models.
    Ohmi T; Konaka S; Uchida M; Yamaguchi H
    Arzneimittelforschung; 1991 Aug; 41(8):847-51. PubMed ID: 1781809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual presentation of tinea cruris due to Trichophyton mentagrophytes var. mentagrophytes.
    Khosravi AR; Mansouri P; Naraghi Z; Shokri H; Ziglari T
    J Dermatol; 2008 Aug; 35(8):541-5. PubMed ID: 18789076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tinea pedis acquired in mosques?
    Veraldi S; Esposito L; Gorani A
    Mycoses; 2018 Nov; 61(11):794-795. PubMed ID: 29600810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo antidermatophyte activities of NND-502, a novel optically active imidazole antimycotic agent.
    Niwano Y; Kuzuhara N; Kodama H; Yoshida M; Miyazaki T; Yamaguchi H
    Antimicrob Agents Chemother; 1998 Apr; 42(4):967-70. PubMed ID: 9559824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperkeratotic chronic tinea pedis treated with neticonazole cream. Neticonazole Study Group.
    Tsuboi R; Matsumoto T; Ogawa H
    Int J Dermatol; 1996 May; 35(5):371-3. PubMed ID: 8734665
    [No Abstract]   [Full Text] [Related]  

  • 12. Dermatophytid--a misdiagnosed entity?
    Kaaman T; Torssander J
    Acta Derm Venereol; 1983; 63(5):404-8. PubMed ID: 6197839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of long-term tinea pedis with miconazole. Double-blind clinical evaluation.
    Brugmans JP; Van Cutsem JM; Thienpont DC
    Arch Dermatol; 1970 Oct; 102(4):428-32. PubMed ID: 4919243
    [No Abstract]   [Full Text] [Related]  

  • 14. D-optimal experimental approach for designing topical microemulsion of itraconazole: Characterization and evaluation of antifungal efficacy against a standardized Tinea pedis infection model in Wistar rats.
    Kumar N; Shishu
    Eur J Pharm Sci; 2015 Jan; 67():97-112. PubMed ID: 25445834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term remission of two feet-one hand syndrome.
    Seeburger J; Scher RK
    Cutis; 1998 Mar; 61(3):149-51. PubMed ID: 9538957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
    Salehi Z; Fatahi N; Taran M; Izadi A; Badali H; Hashemi SJ; Rezaie S; Daie Ghazvini R; Ghaffari M; Aala F; Barac A; Khodavaisy S
    J Mycol Med; 2020 Jun; 30(2):100935. PubMed ID: 32139093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic investigation of oral itraconazole in stratum corneum level of tinea pedis.
    Morimoto K; Tanuma H; Kikuchi I; Kusunoki T; Kawana S
    Mycoses; 2004 Apr; 47(3-4):104-14. PubMed ID: 15078426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bullous ulcerating tinea.
    Meykadeh N; Waltermann K; Schaller M; Marsch WC; Fischer M
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):846-7. PubMed ID: 19207638
    [No Abstract]   [Full Text] [Related]  

  • 19. Achievement of complete mycological cure by topical antifungal agent NND-502 in guinea pig model of tinea pedis.
    Uchida K; Tanaka T; Yamaguchi H
    Microbiol Immunol; 2003; 47(2):143-6. PubMed ID: 12680717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of tinea pedis with a single pulse of itraconazole.
    Bonifaz A; Saúl A
    Eur J Dermatol; 2002; 12(2):157-9. PubMed ID: 11872413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.